APA (7th ed.) Citation

Schultz, S. A., Apel, A., Preische, O., Kuhle, J., Gordon, B. A., Wang, G., . . . Jucker, M. (2023). IC‐04‐02: SERUM NEUROFILAMENT LIGHT CHAIN LEVELS ARE ASSOCIATED WITH CORTICAL THICKNESS, BETA‐AMYLOID BURDEN, AND CEREBRAL GLUCOSE METABOLISM IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE. Alzheimer's & dementia: the journal of the Alzheimer's Association, 14, P7. https://doi.org/10.1016/j.jalz.2018.06.2050

Chicago Style (17th ed.) Citation

Schultz, Stephanie A., et al. "IC‐04‐02: SERUM NEUROFILAMENT LIGHT CHAIN LEVELS ARE ASSOCIATED WITH CORTICAL THICKNESS, BETA‐AMYLOID BURDEN, AND CEREBRAL GLUCOSE METABOLISM IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 14 (2023): P7. https://doi.org/10.1016/j.jalz.2018.06.2050.

MLA (9th ed.) Citation

Schultz, Stephanie A., et al. "IC‐04‐02: SERUM NEUROFILAMENT LIGHT CHAIN LEVELS ARE ASSOCIATED WITH CORTICAL THICKNESS, BETA‐AMYLOID BURDEN, AND CEREBRAL GLUCOSE METABOLISM IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE." Alzheimer's & Dementia: The Journal of the Alzheimer's Association, vol. 14, 2023, p. P7, https://doi.org/10.1016/j.jalz.2018.06.2050.